Intracoronary Adenovirus-Mediated Delivery and Overexpression of the β 2 -Adrenergic Receptor in the Heart

Author:

Shah Ashish S.1,Lilly R. Eric1,Kypson Alan P.1,Tai Oliver1,Hata Jonathan A.1,Pippen Anne1,Silvestry Scott C.1,Lefkowitz Robert J.1,Glower Donald D.1,Koch Walter J.1

Affiliation:

1. From the Departments of General and Thoracic Surgery (A.S.S., R.E.L., A.P.K., O.T., J.A.H., S.C.S., D.D.G, W.J.K.), Pharmacology and Cancer Biology (W.J.K.), Medicine and Biochemistry (A.P., R.J.L.), and The Howard Hughes Medical Institute (R.J.L.), Duke University Medical Center, Durham, NC.

Abstract

Background —Genetic modulation of ventricular function may offer a novel therapeutic strategy for patients with congestive heart failure. Myocardial overexpression of β 2 -adrenergic receptors (β 2 ARs) has been shown to enhance contractility in transgenic mice and reverse signaling abnormalities found in failing cardiomyocytes in culture. In this study, we sought to determine the feasibility and in vivo consequences of delivering an adenovirus containing the human β 2 AR cDNA to ventricular myocardium via catheter-mediated subselective intracoronary delivery. Methods and Results —Rabbits underwent percutaneous subselective catheterization of either the left or right coronary artery and infusion of adenoviral vectors containing either a marker transgene (Adeno-βGal) or the β 2 AR (Adeno-β 2 AR). Ventricular function was assessed before catheterization and 3 to 6 days after gene delivery. Both left circumflex– and right coronary artery–mediated delivery of Adeno-β 2 AR resulted in ≈10-fold overexpression in a chamber-specific manner. Delivery of Adeno-βGal did not alter in vivo left ventricular (LV) systolic function, whereas overexpression of β 2 ARs in the LV improved global LV contractility, as measured by dP/dt max , at baseline and in response to isoproterenol at both 3 and 6 days after gene delivery. Conclusions —Percutaneous adenovirus-mediated intracoronary delivery of a potentially therapeutic transgene is feasible, and acute global LV function can be enhanced by LV-specific overexpression of the β 2 AR. Thus, genetic modulation to enhance the function of the heart may represent a novel therapeutic strategy for congestive heart failure and can be viewed as molecular ventricular assistance.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Cited by 111 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3